Double-Enzymes-Mediated Bioluminescent Sensor for Quantitative and Ultrasensitive Point-Of-Care Testing

Yiping Chen,Yunlei Xianyu,Jing Wu,Mingling Dong,Wenshu Zheng,Jiashu Sun,Xingyu Jiang
DOI: https://doi.org/10.1021/acs.analchem.7b00239
IF: 7.4
2017-01-01
Analytical Chemistry
Abstract:We report an ultrasensitive, quantitative, and rapid bioluminescent immunosensor (ABS) for point-of-care testing (POCT) of the disease biomarker in clinical samples using double enzymes including alkaline phosphatase (ALP) and luciferase. In the presence of the biomarker, the ALP attached on the surface of immuno-nanocomplex dephosphorylates adenine triphosphate (ATP), subsequently inhibiting the ATP luciferin luciferase bioluminescent reaction. The highly sensitive response of ATP (picomolar level) allows for ultrasensitive detection of biomarker via the effective change of the bioluminescence intensity through ALP- and luciferase-catalyzed reactions, which can be quantitatively determined by a portable ATP detector. This ABS fulfills the criteria for POCT that performs sensitive (femtomolar level of biomarkers) and quantitative measurement quickly (less than 1 h) with minimal equipment (portable detector).
What problem does this paper attempt to address?